MedPath

Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management

Phase 4
Completed
Conditions
Ambulatory Surgery
Coughing
Interventions
Drug: Saline
Registration Number
NCT01368809
Lead Sponsor
Cedars-Sinai Medical Center
Brief Summary

The purpose of this research is to evaluate the effectiveness of fentanyl for reducing coughing during the perioperative period (i.e., insertion of an LMA \[Laryngeal Mask Airway\] device, maintenance period during surgery, and awakening \[emergence\] from general anesthesia) for ambulatory surgery procedures. Also to assess the effects of fentanyl on the postoperative outcomes, (e.g., pain, postoperative nausea and vomiting, return of bowel function \[constipation\], resumption of normal activities of daily living).

Fentanyl is one of the most common used anesthetic adjuncts for ambulatory surgery because of its anesthetic-sparing effects and alleged ability to reduce coughing during instrumentation of the patient's airway.

Detailed Description

This research study is designed to evaluate the effects of fentanyl when administered as an adjuvant to standard anesthetic and analgesic drugs on coughing (during insertion of an LMA device, during maintenance and emergence from general anesthesia) and on the postoperative adverse outcomes (i.e., side effects).

All patients will receive local anesthetics and commonly used non-opioid pain relieving medications during surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FentanylFentanylFentanyl (50 µg/ml) 2 ml at induction, 1-2 ml boluses as needed
Saline SolutionSalineSaline Solution 2 ml at induction, 1-2 ml boluses as needed
Primary Outcome Measures
NameTimeMethod
Incidence of Coughingone day

during the perioperative period (insertion of an LMA device, maintenance of anesthesia, and emergence from general anesthesia) for ambulatory surgery procedures.

Secondary Outcome Measures
NameTimeMethod
Postoperative Painone day

Postoperative pain measured using a Verbal Rating Scale (VRS) at post-anesthesia care unit (PACU), (90 minutes after arriving).

Postoperative pain VRS scores: 0 = none pain to 10 = intolerable pain.

Incidence of Nausea and Vomiting1 day

Postoperative nausea and vomiting using a Verbal Rating Scale (0-10) at PACU (post-anesthesia care unit.

Trial Locations

Locations (1)

Cedars Sinai Medical center

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath